EFFECTIVE MANAGEMENT OF HEMOLYTIC COMPLICATIONS BY TRADITIONALLY PREPARED KÄ€NTAM FORMULATIONS
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 9, Issue 2
Abstract
Objective: KÄntam based formulations are unique herbo-metallic preparations, used in Siddha system of medicine (Indian traditional medicine) for managing various haematological complications. Their therapeutic doses were also well established in Siddha literature. In this work an attempt was made to understand the comparative effect of three different kÄntam formulations in the management of hemolytic complications.Methods: Hemolysis was induced in Wistar rats by intraperitoneal injection of acetylphenylhydrazine. Three different kÄntam formulations (KÄntac centÅ«ram1 (K1), KÄntac centÅ«ram2 (K2) and KÄntap paṟpam (K3) were administered with proper controls at their therapeutic doses (20.0 mg/day) for a period of 20 d. Cage side observations, hematological, biochemical and histopathological analysis were performed to understand the effect of the formulations.Results: Cage-side observations revealed that only K1 is effective in curing oral ulcers formed during hemolysis. Haematological analysis revealed the effect of K1 and K3 in regulating reticulocyte maturation and effect of K1, K2 and K3 in the removal of extracellular haemoglobin. Histopathological analysis revealed the effect of K1 in regulating stress erythropoiesis and effect of K1, K2 and K3 in regulating kupffer cells in the liver. Overall, the kÄntam formulations demonstrate an appreciable relevance (in managing hemolytic conditions) within the contemporary pharmacological parlance.Conclusion: Our study demonstrated the effective role of KÄntam formulations in the treatment of hemolytic complications by promoting reticulocyte maturation, removing extracellular haemoglobin, regulating stress erythropoiesis in the spleen, regulating kupffer cells in the liver and preventing oral ulcers. However, all the three formulations did not show all the activities and differ in efficacy profile.
Authors and Affiliations
Geetha Sudheer Rajasekar, P. Brindha, V. Ramanathan
Keywords
Related Articles
- EP ID EP575817
- DOI 10.22159/ijpps.2017v9i2.12728
- Views 39
- Downloads 0
CYTOTOXICITY OF CRUDE EXTRACT FROM SPONGE-ASSOCIATED BACTERIA AGAINST MOLT4 LEUKEMIC CELL LINES THROUGH APOPTOSIS
Objective: The objectives of this study were to isolate bioactive compounds from sponge-associated bacteria and analyze their cytotoxicity against MOLT4 leukemic cell lines through apoptosis.Methods: Crude extract of spo...
PROTECTING OUTCOME OF ETHYL ACETATE FRACTION OF AQUEOUS-METHANOL: 40:60 EXTRACT OF SEED OF MYRISTICA FRAGRANS HOUTT. IN STREPTOZOTOCIN-INDUCED DIABETIC RAT: A DOSE DEPENDENT STUDY
Objective: The investigation has been conducted to find out the threshold dose of ethyl acetate fraction prepared from aqueous-methanol (40:60) extract of seed of Myristica fragrans (Houtt.) from the dose dependent exper...
ANTI-HYPERGLYCEMIC EFFECT OF TERMINALIA CATAPPA FRUIT EXTRACT IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
Objective: To explore the anti-hyperglycemic effect of fruit extract of Terminalia catappa (Indian almond), a potential medicine from plant origin in a diabetic rat model.Methods: Streptozotocin-induced chronic diabetic...
A SELECTIVE AND SENSITIVE METHOD DEVELOPMENT AND VALIDATION BY LC-MS/MS APPROACH FOR TRACE LEVEL QUANTIFICATION OF POTENTIAL GENOTOXIC IMPURITY OF BOC EPOXIDE IN ATAZANAVIR SULPHATE DRUG SUBSTANCE
Objective: To develop and validate a selective, sensitive, rapid and accurate method using LC-MS/MS technique to achieve efficient separation between active pharmaceutical ingredient (Atazanavir sulphate) and genotoxic i...
ZERO, FIRST, SECOND ORDER DERIVATIVE AND AREA UNDER CURVE SPECTROPHOTOMETRIC METHODS FOR DETERMINATION OF CEFIXIME TRIHYDRATE IN PHARMACEUTICAL FORMULATION
Objective: A simple, accurate, precise and specific zero, first, second order and area under curve spectrophotometric methods has been developed for determination of Cefixime Trihydrate in its tablet dosage form by using...